These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 13912488)
1. [Ketophenylbutazone, its metabolism and its effect on the uric acid content in the blood and urine]. SIBLIKOVA O; LAVICKA J; VACHEK G; TESAREK B; VITULOVA O; CERNA M Arzneimittelforschung; 1961 Dec; 11():1106-8. PubMed ID: 13912488 [No Abstract] [Full Text] [Related]
2. [Variations in uric acid in blood and urine during incorporation of phenylbutazone]. SCHAPOSNIK F; DE FALCO JC; GUTIERREZ A Prensa Med Argent; 1956 Feb; 43(5):429-32. PubMed ID: 13335761 [No Abstract] [Full Text] [Related]
3. [Contribution to the metabolism of ketophenylbutazone. II. Ketophenylbutazone metabolites in urine]. SIBLIKOVA O; CERNA M; HAIS IM Cesk Farm; 1962 Mar; 11():123-6. PubMed ID: 13912486 [No Abstract] [Full Text] [Related]
4. [Effects of a uricosuric agent associated with the thermal diuresis treatment on uricemia and the excretion of uric acid in 50 hyperuricemic gout patients. Comparison of the action in patients with simple gout and trophic gout]. MUGLER A Rein Foie; 1961 4th Trimest; 2():147-60. PubMed ID: 14476992 [No Abstract] [Full Text] [Related]
5. Effect of phenylbutazone on uric acid metabolism. MASON RM Br Med J; 1954 Apr; 1(4865):788-92. PubMed ID: 13140862 [No Abstract] [Full Text] [Related]
6. [On the uricosuric effect of a sulfoxide analogue of phenylbutazone]. JUNGBLUTH H; MARTIN H Chemotherapia (Basel); 1961; 3():487-94. PubMed ID: 14452809 [No Abstract] [Full Text] [Related]
7. [Effect of pyrasanone on uric-acid metabolism as revealed by rapid fructose infusion]. Procaccio P Clin Ter; 1977 Oct; 83(2):151-61. PubMed ID: 579339 [No Abstract] [Full Text] [Related]
11. The effect of phenylbutazone on uric acid metabolism in two normal subjects. WYNGAARDEN JB J Clin Invest; 1955 Feb; 34(2):256-62. PubMed ID: 13233347 [No Abstract] [Full Text] [Related]
14. [Contribution to the metabolism of ketophenylbutazone. I]. SIBLIKOVA O; VACHEK J; CERNA M; TESAREK B; VITULOVA V Cesk Farm; 1962 Mar; 11():118-23. PubMed ID: 13912489 [No Abstract] [Full Text] [Related]
15. [Modern differential-therapeutic aspects of the drug therapy of chronic gout]. Schröder HE; Thiele P; Heidelmann G Z Gesamte Inn Med; 1979 Sep; 34(18):523-6. PubMed ID: 583191 [TBL] [Abstract][Full Text] [Related]
16. [Effect of ketophenylbutazone on the renographic tracing examined with hippuran I-131]. Huvar A; Sitar J Vnitr Lek; 1969 Apr; 15(4):326-31. PubMed ID: 5780934 [No Abstract] [Full Text] [Related]
17. Sulphinpyrazone in the treatment of arthritis associated with hyperuricaemia. GLICK EN Proc R Soc Med; 1961 May; 54(5):423-6. PubMed ID: 13706053 [No Abstract] [Full Text] [Related]
19. [Determination of ketophenylbutazone in the blood serum by means of gas chromatography]. Szelepcsényiová A; Hrivnák J; Zathurecký L Cesk Farm; 1976 Dec; 25(10):400-2. PubMed ID: 1037287 [No Abstract] [Full Text] [Related]
20. EFFECT OF SULFINPYRAZONE ON SERUM URIC ACID IN GOUT. A LONG-TERM STUDY. KUZELL WC; GLOVER RP; GIBBS JO; BLAU RA Geriatrics; 1964 Dec; 19():894-909. PubMed ID: 14226251 [No Abstract] [Full Text] [Related] [Next] [New Search]